Tips on how to manage your PhD stipend FIND OUT MORE
Martin Luther University of Halle-Wittenberg Featured PhD Programmes
University of West London Featured PhD Programmes
Queen’s University Belfast Featured PhD Programmes

Characterizing novel molecular targets for genome-informed precision cancer medicine

School of Biomedical Sciences

Applications accepted all year round Funded PhD Project (Students Worldwide)

About the Project

Ovarian cancer is a leading cause of cancer death in women. Identification of novel, actionable and effective strategies to treat the disease could significantly contribute to the improvement of patient survival. Genomic aberrations in cancer may represent synthetic lethal targets because cancer cells harboring particular aberrations are contextually more vulnerable to therapeutics than normal cells.

This PhD project will focus on characterizing genomic mutations that cause deregulation of signaling pathway and susceptibility of ovarian cancer cells to cancer therapies. The project involves genetic screens, function and pathway analyses as well as anti-cancer drug assays. This research will reveal critical mechanisms determining therapeutic responses in ovarian cancer, with potential translational impact on patient survival.

This is an exciting opportunity to identify new approach to treat cancer. We are looking for candidates who are highly motivated, fluent in English with wet lab experience in biological or biomedical science. Students will become proficient in cell culture, tumor biology, a wide range of cellular and molecular techniques, and omics analyses.

Dr. Lydia Cheung has a keen interest in genomic characterization and the associated signaling of cancer, through which we will understand the biology of treatment response and drug resistance. We have identified a number of genomic alterations that may inform therapeutic responses.

Further details about our work are available at:

Faculty information, funding opportunities and application deadlines:


(1) Rao L et al. p85β regulates autophagic degradation of AXL to activate oncogenic signaling. 2020. Nature Communications 11(1):2291.

(2) Li X et al. Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer. 2019. Nature Communications 10 (1), 716.

(3) Cheung LW et al. Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. 2014 Cancer Cell 26 (4), 479-494.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to University of Hong Kong will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2021
All rights reserved.